South Asia’s First Skywalker ™, Orthopedic Robotic System Launched at Yenepoya-Specialty Hospital, Mangaluru
Posted in :
Yennepoya Specialty Hospital has become the first medical institution in south asia to introduce the Skywalker ™ Orthopedic Robotic System for Knee Replacement Suurgery, In Collability with the use Microport Orthopedics Inc. The landmark launch reinforces is the leader’s Leadership in Adopting Advanced Technologies to Enhance Patient Care.
Medical Leaders with Skywalker Robotic System
The Skywalker ™ Orthopedic Robotic System is the only Robotic Platform Worldwide Designed Specifically to Work With the Evolution Medial-Pivot Knee System. Togeether, they enable unparaleled accuracy and sub-milimetre precision in knee joint align Improvement in Stability and Function, Leading to Faster Recovery, Long-Term Durability and A Natural Feeling Knee during daily Chores and Activities, Activities, Including long walks that do not strain the quadry Climbing Stairs and Deep Flexion that Feel Stable.
 |
(From right) Dr Muhammad Thahir, Dr Deepak Rai, Dr Mukesh Parmar
,Yennepoya has Always Been Committed to Integrating Innovations that make a real difference for our patients“Said Dr. Muhammad Thahir, Medical Director, Yenepoya Specialty Hospital,The launch of Skywalker,
Dr. Deepak Rai, Chief Orthopaedic and Joint Replacement Surgeon At Yenepoya, Performed India’s First Skywalker ™ procedus. He noted, “The Skywalker ™ Robotic System Gives Us Real-Time Data for Joint Line Reconstruction and Ligament Balancing, While The Patent Medial-Privot Design of Evolution Mimics The Knee’s Natural Motion. In our initial cases, we are alredy seeing smother recoveries, better range of motion and excellent functional outcomes,
Globally, the adoption of Robotic Systems in Orthopedics has surged. In the united states, more than 40% of knee replacement surgeries are now performed robotically, a number projection to rain steadily. Robotics offer Higher Accuracy, Lower Revision Rates, and Faster Rehabilitation-Benefits that Patients in India will now experience the first-hand at Yeneepoya.
Dr. Mukesh Parmar, Senior Director and General Manager, South Asia, Microport OrthopedicsSaid, “The choice of implant is as critical as the robotic platform itself, beCause it stays with the patient for life. The evolution medial-prote knee has shown 95% Patient Satisfaction, 98.8% Survivorship at 17 years, and Nearly 80% forgotten Joint Scores Worldwide. When Paired with Skywalker ™, It Creates a Powerful Combination that Empowers Surgeons and Delivers Customized and Consistently Favorable PATINT OUTUSCES. We are excited to launch this system at an estered center like yenepoya and togeether setting a new benchmark in line with global standards for orthopedic care in the region,
About Microport Orthopedics Inc.
Microport Orthopedics Inc. Leverages Decades of Orthopedic Expertise and Excellent Clinical Results to Improve Patient Outcomes and Drive Provider Satisfaction Worldwide. Its mission is to partner with surgeons in redefining hip and knee replacements to meet the demands of today’s patients. With a Focus on Innovation and a Commitment to Helping Patients Achieve full function, Faster, Microport Orthopedics Supports Healthcare Providers in Delivering World-Class CLAS CHERE EVRY DATE. Learn more at www.microportortho.com,
About Yenepoya Specialty Hospital
Yennepoya Specialty Hospital is part of the Yenepoya Group, One of South India’s Leading HealthCare Institutions Known for Clinical Excellence, PATINICAL EXCELLENCE, PATINT-CENTRIC CARARE, and Advancedical Technology. The Hospital Provides Comprehensive Services Across Specials and is Committed to Delivering Cutting-Edge Healthcare Solutions to its patients.
About Skywalker ™ Robotic System
The Skywalker ™ Robotic System is the World’s only Robotic Platform Purpose-Built for Use with the evolution Medial-Privot Knee System. It provides surgeons with sub-milimetre accuracy in kineematic alignment, real-time data for decision support, and a seamless integration into surgical workflows, enhanced plan and beetter Patient outcomes.
